|
 |
賽恩生醫科技股份有限公司之前身為拜寧奈米生醫股份有限公司，由旅美華人Dr. Sinclair T. Wang 創立2008年，為台灣第一家以人體成體脂肪幹細胞為研究開發主題之公司，當時台灣之幹細胞科技仍停留於臍帶血儲存和造血幹細胞配對應用之偶然機遇。如今幹細胞科技已經進展到間質系幹細胞之自體和異體臨床應用之階段，以實驗室規模生產成體間質系幹細胞之拜寧奈米生醫已經達成其階段性任務。未來決定幹細胞相關之再生修復醫學，回春醫學，器官組織培養等，均要仰賴於生物醫學工程，將實驗室規模之生產提升至生物反應器之量產規模，於三維空間中模擬人體中之擬二維附著生長環境，再生修復醫學之夢想方可成真。 賽恩生醫科技股份有限公司，乃是針對突破上述之瓶頸，來使在生醫學得以向前進展而成立。其宗旨乃是要藉著幹細胞科技，細胞培養工程以 及組織工程學的結合，跨科學和工程的交互靈活運用， 靠著不斷地研究創新， 來為未來革命性的幹細胞再生和修復醫學，也就是人類器官和組織的健全的維護， 盡上一份科學人和生物工程師該有的社會責任，以紓解人類長期以來一直無法解決，因器官組織受損或老化的 衰老和病痛的問題， 更期盼能朝著人類未來的長壽和永春邁進。 |
 |
賽恩生醫科技由下列專門科研單位組成 |
| 幹細胞培養科技研發中心 |
幹細胞冰凍儲存中心 |
| 細胞生化因子研發中心 |
奈米生物材料研發中心 |
| 電腦影像3D快速造型中心 |
人體器官組織培養研發中心 |
| 再生修復醫學應用研發中心 |
醫學美容應用研發中心 |
| 再生醫學研究醫院策略聯盟處 |
醫學美容研究醫院策略聯盟處 |
|
期盼藉著上述各類跨學術領域的研究單位，專業地分工合作和整合，賽恩生醫
科技能夠使人類保養和維護身體健康的預防醫學和再生修復醫學，跳躍入
一個斬新的科技境界， 人類的文明也因此得以從肉體的老化和病痛中求得解脫，而能在精神文明尚能更上一層樓地進化。 |
|
|
|
|
Omnigrace 3R Center offers access to individualized stem cell treatment plans. Most stem cell treatment centers and clinics offer a standard treatment utilizing an IV or direct injections. We believe the key to the most effective stem cell treatment is through treatment plan customization. As each patient’s disease is different, each treatment must be tailored around their specific disease related complications and symptoms. This is why Omnigrace 3R Center offers access to individualized treatment plans which consist of targeted administration methods to hone in on each part of the body where the complications exist. Through customized, targeted stem cell treatment plans our goal is to offer patients access to stem cell treatment options a patient can truly benefit from to significantly improve one’s quality of life. |
|
|
|
|
*Disclaimer: All information presented through this web site has not been evaluated by USFDA or whichever governing agency worldwide,and is not intended to diagnose, treat, cure or prevent any disease. These products are neither formulated
nor prescribed for any medical condition.
They are formulated for use as an important skin care and dietary supplement product.
© All rights reserved by Omnigrace Lifetech, Inc. 2020
|
|
